Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform

Enable Cloud Platform to be Available with Canopy CellScape System for High-Plex Spatial Biology ST. LOUIS & MENLO PARK, Calif.–(BUSINESS WIRE)–$BRKR #BRKR–Canopy Biosciences, a Bruker Company, and Enable Medicine, today announced a partnership to provide Enable Medicine’s advanced analysis pipelines for spatial omics data with the Canopy CellScape™ system for quantitative high-plex spatial biology. The … [Read more…]

Melissa Smith Joins ATF Medical’s Adaptive Housing Team

Smith brings over 22 years’ experience and home modification expertise to the role. NEWNAN, Ga.–(BUSINESS WIRE)–#OT–Melissa Smith, OTR/L, CAPS, ECHM, CHAMP recently joined ATF Medical as clinical specialist/adaptive housing. In this role, Smith assesses injured workers and their homes and recommends ways to address barriers to accessibility, mobility and independence. “Melissa has dedicated her OT … [Read more…]

Cutera, Inc. Announces Executive Leadership and Governance Changes

Independent Board Member Sheila A. Hopkins Appointed Interim CEO; Search for Permanent CEO Underway Janet D. Widmann Appointed Independent Chair Executive Chairman Daniel Plants and CEO David Mowry Terminated for Cause Withdraws 2023 Outlook BRISBANE, Calif.–(BUSINESS WIRE)–CUTERA, INC. (the “Company”) (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced significant changes to … [Read more…]

Global Lateral Flow Assays Market to 2031: Increasing Prevalence of Home-Based Lateral Flow Tests Drives Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Lateral Flow Assays Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031” report has been added to ResearchAndMarkets.com’s offering. This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for … [Read more…]

Global Infant Oxygen Hoods Market to 2031: Rising Demand for Advanced Respiratory Treatments Drive Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Infant Oxygen Hoods Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031” report has been added to ResearchAndMarkets.com’s offering. This study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) … [Read more…]

Revitalist Enters Joint-Venture Partnership with GCM Partners, LLC, Expanding Access to an Additional 50,000 patients

VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) announces an exciting joint-venture partnership where Revitalist will gain access to five new locations in Chicago, IL (2), Orlando, FL (2), and Miami, FL. These centrally located offices will now be able to serve patients with the … [Read more…]

Global Insulin Pump Market Outlook and Forecasts Report 2023: A $6+ Billion Market by 2028 – Technological Advancements Are Revolutionizing the Insulin Delivery – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Insulin Pump Market – Global Outlook and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global insulin pump market market is projected to reach a value of $6,001.24 million by 2028 from $3,686.82 million in 2022, growing at a CAGR of 8.5% Technological Advancements Are Revolutionizing the Insulin Delivery The insulin … [Read more…]

Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Central Nervous System Partnering 2016-2023: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Central Nervous System Partnering 2016 to 2010 provides the full collection of central nervous system disease deals signed between the world’s pharmaceutical and biotechnology companies since 2016. Trends in central nervous system partnering deals … [Read more…]

Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016 to 2023: Featuring Abbott, Eli Lilly, GSK, Novartis & Hundreds More – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016 to 2023” report has been added to ResearchAndMarkets.com’s offering. The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and … [Read more…]

Almirall, The First to Assess Wellbeing in a Dermatology Clinical Study

The protocol of the POSITIVE study, published in the British Medical Journal (BMJ)1, applies the 5-item World Health Organization Wellbeing Index, WHO-5, to capture wellbeing in moderate to severe psoriasis patients under tildrakizumab treatment in a real world setting Although almost 8 out of 10 people with psoriasis feel that the disease negatively affects their … [Read more…]